Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AMMECR1 intronic transcript 1 (AMMECR1-IT1) is a long non-coding RNA transcribed from an intronic region of the AMMECR1 gene on the X chromosome. Its specific biological functions have not been definitively established. Intronic transcripts such as AMMECR1-IT1 may regulate gene expression by influencing mRNA cleavage, polyadenylation, or splicing dynamics, and may help fine-tune cellular differentiation and identity in stem cells[3]. However, AMMECR1-IT1 itself is not recognized as a protein, receptor, enzyme, transporter, or other established therapeutic target in the current literature or drug development databases[1][3]. The protein-coding gene AMMECR1, from which this transcript originates, is associated with cell proliferation and developmental disorders, but this is distinct from the transcript itself[4][5]. Key clarification: AMMECR1-IT1 should not be confused with the AMMECR1 protein or gene, which is sometimes implicated in disease[1][4][5]. There is no evidence that AMMECR1-IT1 is a direct target for therapeutic intervention, nor are there known drugs that interact with this RNA transcript[1]. If you require information on the protein-coding gene AMMECR1 (AMMECR nuclear protein 1), let me know—this is a separate entity with established biological and disease roles[4][5][6][7].
Not applicable (lncRNAs are generally not targeted by drugs; no drugs or mechanism of action described)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AMMECR1 intronic transcript 1 (AMMECR1-IT1).